Publications | Lund University Publications

1 – 10 of 33

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author%3D%22Bergh%2C+J%22+or+(documentType+any+%22bookEditor+conferenceEditor%22+and+editor%3D%22Bergh%2C+J%22)&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
next »

2021
Mark Prognostic role of serum thymidine kinase 1 kinetics during neoadjuvant chemotherapy for early breast cancer
Matikas, A. ; Wang, K. ^LU ; Lagoudaki, E. ; Acs, B. ; Zerdes, I. ; Hartman, J. ; Azavedo, E. ; Bjöhle, J. ; Carlsson, L. and Einbeigi, Z. , et al. (2021) In ESMO Open 6(2).
- Contribution to journal › Article
2019
Mark Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities : further results from the prospective PANTHER study with focus on obese patients
Matikas, A. ; Foukakis, T. ; Moebus, V. ; Greil, R. ; Bengtsson, N. O. ; Steger, G. G. ; Untch, M. ; Johansson, H. ^LU ; Hellström, M. and Malmström, P. ^LU , et al. (2019) In Annals of oncology : official journal of the European Society for Medical Oncology 30(1). p.109-114
- Contribution to journal › Article
2018
Mark A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1)
Lindman, H. ; Andersson, M. ; Ahlgren, J. ; Balslev, E. ; Sverrisdottir, A. ; Holmberg, S. B. ; Bengtsson, N. O. ; Jacobsen, E. H. ; Jensen, A. B. and Hansen, J. , et al. (2018) In European Journal of Cancer 94. p.79-86
- Contribution to journal › Article
2017
Mark High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer
Paulsson, J. ; Rydén, Lisa ^LU ; Strell, C ; Frings, O ; Tobin, Nicholas P ^LU ; Fornander, T. ; Bergh, J. ; Landberg, Göran ^LU ; Ståhl, O. and Östman, A. (2017) In The Journal of Pathology: Clinical Research 3(1). p.38-43
- Contribution to journal › Article
2015
Mark Molecular subtype and tumor characteristics of breast cancer metastases as assessed by gene expression significantly influence patient post-relapse survival
Tobin, N. P. ; Harrell, J. C. ; Lovrot, J. ; Egyhazi Brage, S. ; Frostvik Stolt, M. ; Carlsson, L. ; Einbeigi, Z. ; Linderholm, B. ; Loman, Niklas ^LU and Malmberg, Martin ^LU , et al. (2015) In Annals of Oncology 26(1). p.81-88
- Contribution to journal › Article
2014
Mark Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events
Karlsson, E. ; Sandelin, K. ; Appelgren, J. ; Zhou, W. ; Jirström, Karin ^LU ; Bergh, J. and Warnberg, F. (2014) In European Journal of Cancer 50(3). p.517-524
- Contribution to journal › Article
Mark Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial
Bonnefoi, H. ; Litiere, S. ; Piccart, M. ; MacGrogan, G. ; Fumoleau, P. ; Brain, E. ; Petit, T. ; Rouanet, P. ; Jassem, J. and Moldovan, C. , et al. (2014) In Annals of Oncology 25(6). p.1128-1136
- Contribution to journal › Article
2013
Mark Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel
Linderholm, B. K. ; Lidbrink, E. ; Tallroth, E. ; Einbeigi, Z. ; Svensson, H. ; von Wachenfeldt, A. ; Norberg, B. ; Carlsson, L. ; Olsson, M. E. and Bergh, J. , et al. (2013) In Breast 22(6). p.1142-1147
- Contribution to journal › Article
Mark Serum thymidine kinase activity compared with CA 15-3 in locally advanced and metastatic breast cancer within a randomized trial
Bjohle, J. ; Bergqvist, J. ; Gronowitz, J. S. ; Johansson, H. ; Carlsson, L. ; Einbeigi, Z. ; Linderholm, B. ; Loman, Niklas ^LU ; Malmberg, M. and Söderberg, Marcus , et al. (2013) In Breast Cancer Research and Treatment 139(3). p.751-758
- Contribution to journal › Article
2012
Mark Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial
Hatschek, T. ; Carlsson, L. ; Einbeigi, Z. ; Lidbrink, E. ; Linderholm, B. ; Lindh, B. ; Loman, Niklas ^LU ; Malmberg, M. ; Rotstein, S. and Soderberg, M. , et al. (2012) In Breast Cancer Research and Treatment 131(3). p.939-947
- Contribution to journal › Article

« previous
1
2
3
4
next »

your query:: Remove author: Bergh, J